Chinese animal vaccine supplier ZYBT.US has increased its IPO size to raise $7 million.

Chinese animal vaccine supplier focusing on the livestock industry, ZYBT.US, has increased the proposed size of its upcoming initial public offering (IPO). The company currently plans to issue 1.5 million shares at a price of $4-5 per share to raise $7 million, a 20% increase from the initial plan. The company intends to list on Nasdaq under the ticker symbol "ZYBT". Established in 2004, ZYBT.US specializes in research, development, manufacturing, and sales of animal vaccines, with a focus on livestock vaccines. Its product portfolio currently includes 43 animal vaccines, covering all major vaccines for animals such as pigs and cattle, and is also developing vaccines for domestic pets such as dogs. ZYBT.US sells its products in 29 provincial-level regions in China and exports to overseas countries including Vietnam, Pakistan, and Egypt. Data shows that the company had sales of $29 million in the 12 months ending December 31, 2023.